Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity.
- 1 September 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 4 (5) , 575-580
- https://doi.org/10.1161/01.hyp.4.5.575
Abstract
We studied the effects of anteroventral third ventricle (AV3V) lesions on the vascular Na+-pump activity of deoxycorticosterone acetate-salt (DOCA-salt) treated rats. Blood pressures and Na+-pump activity of the isolated tail arteries, measured as ouabain-sensitive 86Rb-uptake, were determined in untreated control rats, DOCA-salt treated rats, rats with AV3V lesions, and rats with AV3V lesions which were treated with DOCA-salt. Control rats receiving DOCA treatment developed higher blood pressures than rats receiving no DOCA treatment. Placement of AV3V lesions prior to administration of DOCA prevented the increase in blood pressure. Vascular Na+-pump activity in the DOCA-treated group was reduced by 20% compared to all other groups. The AV3V lesions prevented the suppression of Na+-pump activity caused by DOCA treatment. Suppression of vascular Na+-pump activity was due to a humoral substance since Na+-pump activity of tail arteries from control rats incubated in plasma from DOCA-salt treated rats was suppressed by 25% when compared to those incubated in control plasma. Our findings support the hypothesis that a circulating pressor substance is at least partially responsible for the development of DOCA-salt hypertension and that the mechanism by which AV3V lesions prevent DOCA hypertension may be through the interruption of secretion, transport, or synthesis of this factor.This publication has 23 references indexed in Scilit:
- Sodium pump activity in arteries of rats with Goldblatt hypertension.Hypertension, 1982
- Sodium pump activity in arteries of Dahl salt-sensitive rats.Hypertension, 1981
- Endogenous digitalis-like substance in plasma of volume-expanded dogsNature, 1980
- Abnormal cation composition and transport in erythrocytes from hypertensive patientsEuropean Journal of Clinical Investigation, 1979
- Humoral factors and the sodium-potassium pump in volume expanded hypertensionLife Sciences, 1979
- The role of humoral agents in volume expanded hypertensionLife Sciences, 1976
- ABNORMAL LEUCOCYTE COMPOSITION AND SODIUM TRANSPORT IN ESSENTIAL HYPERTENSIONThe Lancet, 1975
- Attenuated Vasodilator Responses to K+ in Essential Hypertensive MenJournal of Clinical Investigation, 1974
- Possible role of sodium-calcium pumps in tension development of vascular smooth muscleMicrovascular Research, 1969
- HYPERTENSIVE EFFECT OF BLOOD FROM HYPERTENSIVE DOGSThe Lancet, 1940